A critical role for Rac1 in tumor progression of human colorectal adenocarcinoma cells

American Journal of Pathology

Volumn 172, Issue 1, 2008, Pages 156-166

  Espina, Carolina ^a   Céspedes, María Virtudes ^b   García Cabezas, Miguel Angel ^a,c   Del Pulgar, María Teresa Gómez ^a   Boluda, Alicia ^a   Oroz, Lourdes García ^a   Cejas, Paloma ^a   Nistal, Manuel ^a,c   Mangues, Ramón ^b   Lacal, Juan Carlos ^a,d  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

RAC1 PROTEIN;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DNA MODIFICATION; GENE TARGETING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR GROWTH;

EID: 38749134864     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.070561     Document Type: Article

References (64)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 2007, 57:43-66
2. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108
3. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 2000, 100:57-70
4. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767
5. Sjöblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE: The consensus coding sequences of human breast and colorectal cancers. Science 2006, 314:268-274
6. Wennerberg K, Der CJ: Rho-family GTPases: it's not only Rac and Rho (and I like it). J Cell Sci 2004, 117:1301-1312
7. Ridley AJ, Hall A: The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 1992, 70:389-399
8. Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A: The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 1992, 70:401-410
9. Nobes CD, Hall A: Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995, 81:53-62
10. Etienne-Manneville S, Hall A: Rho GTPases in cell biology. Nature 2002, 420:629-635
11. Van Aelst L, Symons M: Role of Rho family GTPases in epithelial morphogenesis. Genes Dev 2002, 16:1032-1054
12. Coso OA, Chiariello M, Yu JC, Teramoto H, Crespo P, Xu N, Miki T, Gutkind JS: The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 1995, 81:1137-1146
13. Perona R, Montaner S, Saniger L, Sanchez-Perez I, Bravo R, Lacal JC: Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins. Genes Dev 1997, 11:463-475
14. Murga C, Zohar M, Teramoto H, Gutkind JS: Rac1 and RhoG promote cell survival by the activation of PI3K and Akt, independently of their ability to stimulate JNK and NF-kappaB. Oncogene 2002, 21:207-216
15. Aznar S, Fernandez-Valeron P, Espina C, Lacal JC: Rho GTPases: potential candidates for anticancer therapy. Cancer Lett 2004, 206:181-191
16. Gómez del Pulgar T, Benitah SA, Valeron PF, Espina C, Lacal JC: Rho GTPase expression in tumourigenesis: evidence for a significant link. Bioessays 2005, 27:602-613
17. Boettner B, Van Aelst L: The role of Rho GTPases in disease development. Gene 2002, 286:155-174
18. Attoub S, Noe V, Pirola L, Bruyneel E, Chastre E, Mareel M, Wymann MP, Gespach C: Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways. FASEB J 2000, 14:2329-2338
19. Kawasaki Y, Senda T, Ishidate T, Koyama R, Morishita T, Iwayama Y, Higuchi O, Akiyama T: Asef, a link between the tumor suppressor APC and G-protein signaling. Science 2000, 289:1194-1197
20. Esufali S, Bapat B: Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of betacatenin and TCF/LEF-mediated transcriptional activation. Oncogene 2004, 23:8260-8271
21. Malliri A, Rygiel TP, van der Kammen RA, Song JY, Engers R, Hurlstone AF, Clevers H, Collard JG: The rac activator Tiam1 is a Wntresponsive gene that modifies intestinal tumor development. J Biol Chem 2006, 281:543-548
22. Gomez del Pulgar T, Bandres E, Espina C, Valdes-Mora F, Perez-Palacios R, Garcia-Amigot F, Garcia-Foncillas J, Lacal JC: Differential expression of Rac1 identifies its target genes and its contribution to progression of colorectal cancer. Int J Biochem Cell Biol 2007, 39:2289-2302
23. Céspedes MV, Espina C, Garcia-Cabezas MA, Trias M, Boluda A, del Pulgar MT, Sancho FJ, Nistal M, Lacal JC, Mangues R: Orthotopic microinjection of human colon cancer cells in nude mice induces tumor foci in all clinically relevant metastatic sites. Am J Pathol 2007, 170:1077-1085
24. Brummelkamp TR, Bernards R, Agami R: A system for stable expression of short interfering RNAs in mammalian cells. Science 2002, 296:550-553
25. Aznar S, Valeron PF, del Rincon SV, Perez LF, Perona R, Lacal JC: Simultaneous tyrosine and serine phosphorylation of STAT3 transcription factor is involved in Rho A GTPase oncogenic transformation. Mol Biol Cell 2001, 12:3282-3294
26. Hewitt RE, McMarlin A, Kleiner D, Wersto R, Martin P, Tsokos M, Stamp GW, Stetler-Stevenson WG: Validation of a model of colon cancer progression. J Pathol 2000, 192:446-454
27. Oving IM, Clevers HC: Molecular causes of colon cancer. Eur J Clin Invest 2002, 32:448-457
28. Perona R, Esteve P, Jimenez B, Ballestero RP, Ramon y Cajal S, Lacal JC: Tumorigenic activity of rho genes from Aplysia californica. Oncogene 1993, 8:1285-1292
29. del Peso L, Hernandez-Alcoceba R, Embade N, Carnero A, Esteve P, Paje C, Lacal JC: Rho proteins induce metastatic properties in vivo. Oncogene 1997, 15:3047-3057
30. Olson MF, Ashworth A, Hall A: An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science 1995, 269:1270-1272
31. Coleman ML, Olson MF: Rho GTPase signalling pathways in the morphological changes associated with apoptosis. Cell Death Differ 2002, 9:493-504
32. Jiménez B, Arends M, Esteve P, Perona R, Sanchez R, Ramon y Cajal S, Wyllie A, Lacal JC: Induction of apoptosis in NIH3T3 cells after serum deprivation by overexpression of rho-p21, a GTPase protein of the ras superfamily. Oncogene 1995, 10:811-816
33. Van Aelst L, D'Souza-Schorey C: Rho GTPases and signaling networks. Genes Dev 1997, 11:2295-2322
34. Pruitt K, Der CJ: Ras and Rho regulation of the cell cycle and oncogenesis. Cancer Lett 2001, 171:1-10
35. Benitah SA, Valeron PF, van Aelst L, Marshall CJ, Lacal JC: Rho GTPases in human cancer: an unresolved link to upstream and downstream transcriptional regulation. Biochim Biophys Acta 2004, 1705:121-132
36. Michiels F, Habets GG, Stam JC, van der Kammen RA, Collard JG: A role for Rac in Tiam1-induced membrane ruffling and invasion. Nature 1995, 375:338-340
37. Sahai E, Marshall CJ: RHO-GTPases and cancer. Nat Rev Cancer 2002, 2:133-142
38. Polakis P: Wnt signaling and cancer. Genes Dev 2000, 14:1837-1851
39. Lechner S, Muller-Ladner U, Renke B, Scholmerich J, Ruschoff J, Kullmann F: Gene expression pattern of laser microdissected colonic crypts of adenomas with low grade dysplasia. Gut 2003, 52:1148-1153
40. Shaw LM, Rabinovitz I, Wang HH, Toker A, Mercurio AM: Activation of phosphoinositide 3-OH kinase by the alpha6beta4 integrin promotes carcinoma invasion. Cell 1997, 91:949-960
41. Heijstek MW, Kranenburg O, Borel Rinkes IH: Mouse models of colorectal cancer and liver metastases. Dig Surg 2005, 22:16-25
42. Alencar H, King R, Funovics M, Stout C, Weissleder R, Mahmood U: A novel mouse model for segmental orthotopic colon cancer. Int J Cancer 2005, 117:335-339
43. Flatmark K, Maelandsmo GM, Martinsen M, Rasmussen H, Fodstad O: Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice. Eur J Cancer 2004, 40:1593-1598
44. Qiu RG, Chen J, Kirn D, McCormick F, Symons M: An essential role for Rac in Ras transformation. Nature 1995, 374:457-459
45. Takai Y, Sasaki T, Tanaka K, Nakanishi H: Rho as a regulator of the cytoskeleton. Trends Biochem Sci 1995, 20:227-231
46. Keely PJ, Westwick JK, Whitehead IP, Der CJ, Parise LV: Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K. Nature 1997, 390:632-636
47. Sander EE, ten Klooster JP, van Delft S, van der Kammen RA, Collard JG: Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior. J Cell Biol 1999, 147:1009-1022
48. Murphy LD, Valverius EM, Tsokos M, Mickley LA, Rosen N, Bates SE: Modulation of EGF receptor expression by differentiating agents in human colon carcinoma cell lines. Cancer Commun 1990, 2:345-355
49. Radinsky R, Risin S, Fan D, Dong Z, Bielenberg D, Bucana CD, Fidler IJ: Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res 1995, 1:19-31
50. Carter JH, Douglass LE, Deddens JA, Colligan BM, Bhatt TR, Pemberton JO, Konicek S, Hom J, Marshall M, Graff JR: Pak-1 expression increases with progression of colorectal carcinomas to metastasis. Clin Cancer Res 2004, 10:3448-3456
51. Mohri T, Adachi Y, Ikehara S, Hioki K, Tokunaga R, Taketani S: Activated Rac1 selectively up-regulates the expression of integrin alpha6beta4 and induces cell adhesion and membrane ruffles of nonadherent colon cancer Colo201 cells. Exp Cell Res 1999, 253:533-540
52. McManus MT, Sharp PA: Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 2002, 3:737-747
53. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411:494-498
54. McCaffrey AP, Meuse L, Pham TT, Conklin DS, Hannon GJ, Kay MA: RNA interference in adult mice. Nature 2002, 418:38-39
55. Verma UN, Surabhi RM, Schmaltieg A, Becerra C, Gaynor RB: Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells. Clin Cancer Res 2003, 9:1291-1300
56. Yang G, Thompson JA, Fang B, Liu J: Silencing of H-ras gene expression by retrovirus-mediated siRNA decreases transformation efficiency and tumor growth in a model of human ovarian cancer. Oncogene 2003, 22:5694-5701
57. Xue Y, Bi F, Zhang X, Pan Y, Liu N, Zheng Y, Fan D: Inhibition of endothelial cell proliferation by targeting Rac1 GTPase with small interference RNA in tumor cells. Biochem Biophys Res Commun 2004, 320:1309-1315
58. Chan AY, Coniglio SJ, Chuang YY, Michaelson D, Knaus UG, Philips MR, Symons M: Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion. Oncogene 2005, 24:7821-7829
59. Malliri A, van der Kammen RA, Clark K, van der Valk M, Michiels F, Collard JG: Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours. Nature 2002, 417:867-871
60. Joyce PL, Cox AD: Rac1 and Rac3 are targets for geranylgeranyltransferase I inhibitor-mediated inhibition of signaling, transformation, and membrane ruffling. Cancer Res 2003, 63:7959-7967
61. Menna PL, Skilton G, Leskow FC, Alonso DF, Gomez DE, Kazanietz MG: Inhibition of aggressiveness of metastatic mouse mammary carcinoma cells by the beta2-chimaerin GAP domain. Cancer Res 2003, 63:2284-2291
62. Gao Y, Dickerson JB, Guo F, Zheng J, Zheng Y: Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc Natl Acad Sci USA 2004, 101:7618-7623
63. Lee TK, Man K, Ho JW, Wang XH, Poon RT, Xu Y, Ng KT, Chu AC, Sun CK, Ng IO, Sun HC, Tang ZY, Xu R, Fan ST: FTY720: a promising agent for treatment of metastatic hepatocellular carcinoma. Clin Cancer Res 2005, 11:8458-8466
64. Shan D, Chen L, Njardarson JT, Gaul C, Ma X, Danishefsky SJ, Huang XY: Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice. Proc Natl Acad Sci USA 2005, 102:3772-3776